Journal for ImmunoTherapy of Cancer (Nov 2023)
1272 Two-year experience of BITOX: the Belgian multidisciplinary ImmunoTOXicity board, a nationwide initiative of the Belgian Society for Medical Oncology (BSMO)
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)